RASIO
  • Home
  • Team
  • News
  • Contact

NEWS

Job opening: Biology Research Associate

5/6/2022

 
The person in the role of Biology Research Associate will work with our ventures (including Rasio Therapeutics) in the biotechnology and life-sciences that manufacture and develop products such as DNA libraries, 3D cell printing, oral vaccines and diagnostics for aquaculture, tissue engineering scaffolds, encapsulating enzymes to treat rare diseases, and oncology therapeutics.

Read More

Job Opening: Business Development and Technical Sales for Early Charm’s Drug Design Companies

5/17/2021

 
Rasio Therapeutics' parent company, Early Charm, has a job opening to work with Rasio Therapeutics and other companies in its Drug Design Portfolio: Business Development and Technical Sales for Drug Design Companies

Read More

National Foundation for Cancer Research Launches Partnership with Rasio Therapeutics

11/25/2019

 
NFCR commits $1 million in financing to Rasio Therapeutics to develop treatments targeting cancers with limited treatment options

November 25, 2019, Baltimore, MD – Rasio Therapeutics, Inc., a biopharmaceutical company that develops novel medicines using cutting-edge computer-aided drug design technology, today announced the launch of a formal partnership with the National Foundation for Cancer Research (NFCR). 


Read More

Todd Chappell  Appointed CEO of Rasio Therapeutics

11/13/2019

 
Chappell is a 20-year veteran of the biopharma industry with experience running multiple drug development programs from discovery stage through to clinical trials

​
November 14, 2019, Baltimore, MD – Rasio Therapeutics, Inc., a biopharmaceutical company that develops novel medicines using cutting-edge computer-aided drug design technology, today announced the appointment of Todd Chappell, a veteran medtech and pharmaceutical industry executive, as the company’s CEO.

Read More
Powered by Create your own unique website with customizable templates.
  • Home
  • Team
  • News
  • Contact